Discard any unused solution 28 days after first puncture or on the beyond-use date on the label, whichever comes first
GLP-1s and HRT: The weight loss benefits of a combined approach Combining hormone replacement therapy (HRT) with GLP-1 medications is emerging as one of the most promising new strategies for managing weight and overall well-being during menopause
When the peptide blend, sometimes also called the peptide stack, is presented in combination, research studies typically report that the Ipamorelin exerts initial action, exhibiting some sign of impact within the first two hours of presentation, and as it starts to wean off, the CJC-1295 peptide may gradually supplement action
These solutions are FDA-approved, targeted for weight loss, and available through Klinic
The FDA has since resolved both shortages, tightening but not fully closing that window